FIELD: medicine, pharmacy. SUBSTANCE: vaginal suppository with anti-fungal effect contains nystatin, nypasol, citric acid, hydrophobic base, sea-buckthorn oil and paraffin in the following ratio of components, g per 1 suppository: the first variant: nystatin, 212 500-275 000 U; nypasol, 0.002; citric acid, 0.000075; sea-buckthorn oil, 0.2; paraffin, 0.04-0.06; hydrophobic base, the balance; the second variant: nystatin, 425 000-550 000 U; nypasol, 0.002; citric acid, 0.000075; sea-buckthorn oil, 0.2; paraffin, 0.04-0.06; hydrophobic base, the balance. Invention provides both anti- fungal and anti-inflammatory properties of suppository. EFFECT: valuable properties of suppository, expanded possibility for suppository using. 2 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SUPPOSITORY WITH ANTIFUNGAL EFFECT | 2001 |
|
RU2196586C1 |
SUPPOSITORY EXHIBITING ANTIFUNGAL EFFECT (VARIANTS) | 1996 |
|
RU2139707C1 |
PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION IN GYNAECOLOGY | 2010 |
|
RU2454233C2 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
RECTAL SUPPOSITORY "OLESTEZIN" | 2002 |
|
RU2212882C1 |
TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
ANTIBACTERIAL SUPPOSITORIES | 2015 |
|
RU2595852C1 |
SUPPOSITORY SHOWING ANTIINFLAMMATORY EFFECT | 1995 |
|
RU2097022C1 |
PREPARATION FOR TREATING INFLAMMATORY DISEASES | 2000 |
|
RU2170101C1 |
METHOD OF PRODUCING VAGINAL VELVET ANTLER SUPPOSITORIES FOR WOMEN | 2018 |
|
RU2740655C1 |
Authors
Dates
2003-12-27—Published
2001-10-29—Filed